Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3,4-Diaminopyridine for Demyelinating Polyneuropathy
NCT00004939Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Aug 1996
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of amifampridine in chronic inflammatory demyelinating polyneuropathy (CIDP), Charcot-Marie-Tooth disease type 1 (CMT1), multifocal motor neuropathy (MMN), sponsored by National Center for Research Resources. Started Aug 1996; status: completed.
02
Drugs
amifampridine
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)Charcot-Marie-Tooth disease type 1 (CMT1)multifocal motor neuropathy (MMN)
Beyond the preview
Go deeper on NCT00004939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004939.